Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2025-01-08 00:00:00 ET · period of report 2025-01-08 · accession 0001628280-25-000994 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-08 | 2025-01-08 | VIR | SATO VICKI L | Dir | S - Sale | $12.52 | -11.0K | 1.31M | -0.8% | -$137.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-08 | S | D | 10,960 | $12.52 | 1,312,391 | D | — | — |